AnalystsAndres Maldonado
Andres Maldonado's Stock Forecasts

Sectors:
Industries:
Analyst Ranking
Top 6%
#304 out of 5253 analysts
Average Return
+34.85%
Win Rate
43%40 out of 92
Risk vs Reward
Poor
Good

Andres Maldonado's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Erasca IncERAS
+1,148.63%$1.46$18.23
2025-04-30 -
2026-04-16
Buy
Erasca IncERAS
+854.25%$1.53$14.60
2025-03-21 -
2026-03-20
Buy
Scholar Rock Holding CorpSRRK
+314.00%$8.07$33.41
2024-06-25 -
2025-06-24
Buy
Zentalis Pharmaceuticals IncZNTL
+298.41%$1.26$5.02
2025-05-15 -
2026-04-16
Buy
Scholar Rock Holding CorpSRRK
+228.91%$8.06$26.51
2023-10-12 -
2024-10-11
Buy

Andres Maldonado Analyst Color

Get additional color on Andres Maldonado's coverage of popular stocks

Andres Maldonado's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Novabridge BiosciencesNBP
1Buy$7.00+162.17%Reiterates
9 months ago
Aura Biosciences IncAURA
1Buy$22.00+211.61%Assumes
a year ago
Zentalis Pharmaceuticals IncZNTL
1Buy$10.00+99.20%Reiterates
a year ago
Corbus Pharmaceuticals Holdings IncCRBP
2Buy$40.00+294.48%Maintains
a year ago
Tscan Therapeutics IncTCRX
1Buy$10.00+825.93%Maintains
a year ago
Erasca IncERAS
10Buy$6.00-67.09%Reiterates
a year ago
Foghorn Therapeutics IncFHTX
1Buy$13.00+167.49%Reiterates
a year ago
Sutro Biopharma IncSTRO
1Hold$20.00-31.86%Reiterates
a year ago
Protara Therapeutics IncTARA
1Buy$23.00+348.34%Reiterates
a year ago
Cg Oncology IncCGON
13Buy$75.00+13.05%Reiterates
a year ago
Day One Biopharmaceuticals IncDAWN
14Buy$36.00N/AReiterates
a year ago
Mural Oncology PLCMURA
5Buy$6.00N/AMaintains
a year ago
Werewolf Therapeutics IncHOWL
16Buy$15.00N/AReiterates
a year ago
Engene Therapeutics IncENGN
2Buy$25.00N/AReiterates
a year ago
Scholar Rock Holding CorpSRRK
13Buy$50.00N/AMaintains
a year ago
Imagenebio IncIMA
11Buy$48.00N/AReiterates
a year ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.